Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study

AIMS: Nonvitamin K antagonist oral anticoagulants (NOACs) are now available for the prevention of stroke in patients with atrial fibrillation (AF) as an alternative to vitamin K antagonists (VKA) and aspirin. The comparative effectiveness and safety in daily practice of these different drug classes...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Clin Pharmacol
Asıl Yazarlar: Gieling, Emilie M., van den Ham, Hendrika A., van Onzenoort, Hein, Bos, Jacqueline, Kramers, Cornelis, de Boer, Anthonius, de Vries, Frank, Burden, Andrea M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2017
Konular:
Pharmacoepidemiology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5510083/
https://ncbi.nlm.nih.gov/pubmed/28205318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13265
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller